IMG PHARMA BIOTECH
IMG Pharma Biotech emerges as a university spin-off in 2010, being the result of more than six years of multidisciplinary research with the aim of developing new tools for hight troughput analysis of drugs.
Its core technology is based on cell membrane microarrays. These microarrays are composed of multiple microdots of cell membranes isolated from different organs and tissues, allowing to characterize the action of drugs in each of the organs from which cell membranes were extracted, in a single miniaturized assay, with consequent savings in time, reagents, experimental animals and pollutants.
IMG PHARMA also offers the possibility of immobilizing antibodies and proteins on glass slides or plastic surfaces, according to the clients' needs and specifications.
The currently portfolio of products / services that IMG Pharma offers is:
Cell membrane microarrays for drug analysis by HTS techniques.
Custom development of microchips, immobilizing cell membranes, antibodies and proteins on glass slides or plastic supports.
Analytic services by HTS techniques: IMG Pharma offers not only the microarrays as a product, but also the possibility to perform analysis employing them: the customer may choose to purchase only the microarrays, or order a full analysis on demand.
Conventional services using radiometric analysis techniques.
Radioligand binding and autoradiography, dose-effect curves, in vivo and ex vivo studies.